Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Attention A T users. To access the combo box on this page please perform the following steps. 1. Press the alt key and then the down arrow. 2. Use the up and down arrows to navigate this combo box. 3. Press enter on the item you wish to view. This will take you to the page listed.
Menu
Menu
Veterans Crisis Line Badge
My healthevet badge

VA Federal Supply Schedule Service

 

Notices

US Made Designation Clarification

The Federal Supply Schedule received questions related to the recently upgraded option to include a "US Made" designation for FSS products. Please select this link to review a list of US Made designation Frequently asked Question and Answers. Download the full Q n A.

Vendor Questions and Answers – March 2025 Mass Modification per Executive Order (E.O.) 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity

The Federal Supply Schedule received several questions following the release of the March 2025 Mass Modification that was directed by Executive Order 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity. Please review the Questions and Answers below to clarify issues. Download the full Q n A.

97 highly purchased items

Federal Supply Schedule (FSS) contract holder, VA ordering facilities have contacted FSS and requested that we pursue 97 highly purchased items to be added to the FSS. Product addition modifications for Trades Agreement Act (TAA) compliant versions of these items are encouraged. Please follow the normal Product Request for Modification process to submit any new TAA compliant items.

  1. Abacavir SO4 600mg/Lamivudine 300mg Tab
  2. Acamprosate
  3. Acamprosate CA 333mg EC Tab
  4. Acamprosate CA 333MG TAB
  5. Adapalene 0.1% Gel — Pharmaceutical
  6. Alyacen 1/35 TAB,28
  7. Amitriptyline HCL 50MG tablet
  8. Amlodipine 5mg/Benazepril 20mg Cap
  9. Amlodipine 5mg/Benazepril 40mg Cap
  10. Amlodipine 10mg/Benazepril 20mg Cap
  11. APAP 325MG/Butalbital 50MG/CAFN 40MG TAB
  12. Artificial Saliva (Biotene Mouth) Spray
  13. Artificial Saliva Oral Spray
  14. Azathioprine 50mg tab; Amlodipine 5mg/Benazepril 10mg Cap
  15. Bag Leg Conveen #5170
  16. Barrier Brava Strips C#120700
  17. Breast Milk Storage Bag
  18. Budesonide 0.5MG/2ML INH SUSP 2ML
  19. Camphor-Menthor-Methyl Salicylate Large Patch
  20. Camphor/Menthol/Methyl Salicylate Patch
  21. Camphor Menthol Pain Patch
  22. Cath Set, Intermit 14FR APOGEE H#B14FB
  23. Cefpodoxime Tablets
  24. Cetirizine HCL 5MG TAB
  25. Clamco Film Reel Holders
  26. Clindamycin 1% Topical Solution Pharmaceutical
  27. Clindamycin P04 1% TOP SWAB
  28. Clindamycin Topical Solution
  29. Clomiphene Citrate 50mg Tab
  30. Clomiphene Citrate Pharmaceutical
  31. Clomiphene Citrate tablets
  32. Clonazepam .5MG
  33. Clonazepam 1MG
  34. Clonazepam 2MG
  35. Clonazepam 5MG
  36. Clonazepam 10MG
  37. Contour Next (Glucose) Test Strip 50CT
  38. Contour Next (Glucose) Test Strip 100CT
  39. Darifenacin 7.5mg SA Tab
  40. Diclofenac NA 25MG EC TAB
  41. Eyelid Cleanser, Eye Scrub Pad
  42. Eyelid Cleanser Compliance Kit
  43. Fenofibrate 145MG TAB
  44. Galantamine Hydrobromide 8MG SA CAP
  45. Galantamine Hydrobromide 8mg Tab
  46. Galantamine Hydrobromide 12MG TAB
  47. Galantamine Hydrobromide 16MG SA CAP
  48. Glimepiride 4MG
  49. Glyburide 5mg/Metformin
  50. HCTZ 12.5mg/Valsartan 80mg Tab
  51. Irbesartan 300MG
  52. Lancet, Onetouch Delica Plus 33G
  53. Lansoprazole 15MG SA Disintegrating TAB
  54. Lansoprazole 30MG SA Disintegrating TAB
  55. Lansoprazole 30MG SA Disintegrating TAB
  56. Leg Bag Combination H#9349 LATEX FREE
  57. Magnesium Oxide 140 MG Capsule
  58. Menthol/M-Salicylate 16-30% Top Cream 85GM
  59. Metformin HCL 500MG 24HR SA TAB
  60. Metformin HCL 750MG 24HR SA TAB
  61. Mineral Oil Enema
  62. Mineral Oil, Light/Mineral OIL OPH SOLN
  63. Minoxidil 5% TOP SOLN
  64. Moisturizer VAG GEL (EQV-REPLENS)
  65. Moisturizing Lotion 240 & 480
  66. Naphozoline HCL 0.012% POH SOLN
  67. Nephro-Vite RX TAB
  68. Nevirapine 200MG tab
  69. One Touch Ultra (Glucose) Test Strip 100CT
  70. One Touch Ultra (Glucose) Test Strip 50CT
  71. OneTouch Ultra Glucose Test Strips
  72. Ostomy Venting System (OSTO-EZ-VENT)
  73. PEG-400 0.4%/PROP GLY 0.3% Eye Drops UD
  74. Pentetate Calcium Trisodium and Pentetate Zinc Trisodium — Pharmaceuticals
  75. Permethrin 1% TOP Liquid
  76. Petrolatum (White) OINT 30GM
  77. Polyvinyl Alcohol 1.4% Lubricating Eye Drops
  78. Reservoir, T:SLIM 3ML
  79. Reservoir, T:SLIM W/T:LOCK,3ML
  80. Reservoir T:SLIM X2 W/T:LOCK 3ML
  81. Risperidone 0.5MG tab
  82. Risperidone 4MG
  83. Salicyclic Acid 6% TOP GEL
  84. Set Infusion Autosoft XC TANDEM #1001680
  85. Set, Infusion Autosoft XC TANDEM #1001681
  86. Set, Infusion Minimed #MMT-381A
  87. Sodium Chloride 2% OPH SOLN
  88. Sumatriptan 6MG/0.5ML INJ Syringe 0.5ML
  89. Syringe, Feeding ENFIT 60ML
  90. Tamsulosin — Pharmaceutical
  91. Timolol Maleate .5% OPH Gel
  92. Tobramycin Ophthalmic Solution 0.3% 5mL — Pharmaceutical
  93. Verapamil HCL
  94. XYLITOL ORAL DISC
  95. Zolmitriptan 5MG DISINTEGR TAB PKG 3
  96. Zolpidem Tartrate 6.25MG SA TAB
  97. Zolpidem Tartrate 12.5MG SA TAB
Sales and IFF Clause Change

Per our first notification in March, you were informed that VA FSS will be transitioning the sales reporting and IFF remittance process from the legacy VA Sales Reporting System to GSA’s Federal Acquisition Service (FAS) FAS Sales Reporting Portal (SRP) by the end of CY23.

As part of the upcoming transition, and to align our practices with GSA, we will be shortening the deadline for reporting sales outlined in clause 552.238-80 Industrial Funding Fee and Sales Reporting from 60 to 30 days. Currently VA FSS uses a tailored version of this clause in which we lengthened the reporting time period to 60 days from 30 days (standard clause version).

As this may require adjustments to your internal business operating practices, this advance notice is provided for you to begin preparations for transitioning to the shorter reporting period. The new clause language will be issued via mass modification in late CY23 and take effect on January 1, 2024, coinciding with the transition to the FAS SRP system. You do not have to wait for the new clause language to transition and begin reporting within 30 days after the close of the quarter.

Recommended Action: Please assess the implications of this change and begin preparation to fundamentally change or tweak your internal processes so that you can comfortably achieve Sales report filing and IFF remittance for Quarter 1 of FY 2024 and all subsequent quarters within 30 days after the close of the quarter.